Search


Current filters:

Start a new search
Add filters:

Use filters to refine the search results.


Results 1-9 of 9 (Search time: 0.002 seconds).
  • previous
  • 1
  • next
Item hits:
PreviewIssue DateTitleAuthor(s)
2012Discovery of circulating microRNAs associated with human prostate cancer using a mouse model of diseaseSelth, L.; Townley, S.; Gillis, J.; Ochnik, A.; Murti, K.; Macfarlane, R.; Chi, K.; Marshall, V.; Tilley, W.; Butler, L.
2013Research resource: Nuclear receptors as transcriptome: Discriminant and prognostic value in breast cancerMuscat, G.; Eriksson, N.; Byth, K.; Loi, S.; Graham, D.; Jindal, S.; Davis, M.; Clyne, C.; Funder, J.; Simpson, E.; Ragan, M.; Kuczek, E.; Fuller, P.; Tilley, W.; Leedman, P.; Clarke, C.
2006Circulating insulin-like growth factor-I and binding protein-3 and risk of prostate cancerSeveri, G.; Morris, H.; MacInnis, R.; English, D.; Tilley, W.; Hopper, J.; Boyle, P.; Giles, G.
2007Circulating insulin-like growth factor-I and binding protein-3 and the risk of breast cancerBaglietto, L.; English, D.; Hopper, J.; Morris, H.; Tilley, W.; Giles, G.
2006Variants in the prostate-specific antigen (PSA) gene and prostate cancer risk, survival, and circulating PSASeveri, G.; Hayes, V.; Neufing, P.; Padilla, E.; Tilley, W.; Eggleton, S.; Morris, H.; English, D.; Southey, M.; Hopper, J.; Sutherland, R.; Boyle, P.; Giles, G.
2011GSTP1 DNA methylation and expression status is indicative of 5-aza-2'-deoxycytidine efficacy in human prostate cancer cellsChiam, K.; Centenera, M.; Butler, L.; Tilley, W.; Bianco-Miotto, T.; Agoulnik, I.
2012Protein arginine methyltransferase 6-dependent gene expression and splicing: association with breast cancer outcomesDowhan, D.; Harrison, M.; Eriksson, N.; Bailey, P.; Pearen, M.; Fuller, P.; Funder, J.; Simpson, E.; Leedman, P.; Tilley, W.; Brown, M.; Clarke, C.; Muscat, G.
2012Circulating microRNAs: macro-utility as markers of prostate cancer?Selth, L.; Tilley, W.; Butler, L.
2010Co-expression of the androgen receptor and the transcription factor ZNF652 is related to prostate cancer outcomeCallen, D.; Ricciardelli, C.; Butler, M.; Stapleton, A.; Stahl, J.; Kench, J.; Horsfall, D.; Tilley, W.; Schulz, R.; Nesland, J.; Neilsen, P.; Kumar, R.; Holm, R.